Furthermore, the transcription factor Yin-Yang 1 (YY1) is known to further enhance the effects of PD-L1; therefore, .NO-mediated inhibition of YY1 and subsequent downregulation of PD-L1 further enhances the immune response in cancer [23]. Here, YY1 is linked to cancer.